SCHEMBL3628038

SCHEMBL3628038

Nc1cc(=O)[nH]cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29029022 0.88 PARP1 (0.40)
SCHEMBL28490250 0.83 PARP1 (0.37)
SCHEMBL7970843 0.73 PARP1 (0.59)
SCHEMBL1724206 0.70
SCHEMBL17993348 0.70
SCHEMBL22214107 0.70
SCHEMBL15741258 0.70
SCHEMBL3651169 0.70
SCHEMBL6837616 0.69 PARP1 (0.54)
SCHEMBL6645139 0.69 GDA (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4204413-B1 DIHYDROQUINAZOLIN-2-ONE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS USEFUL IN THE TREATMENT OF HIV MERCK SHARP & DOHME LLC (US) 2024-09-25 EP claimed
US-11648250-B2 Tetrahydroquinazoline derivatives as selective cytotoxic agents MERCK SHARP & DOHME LLC (US) 2023-05-16 US claimed
EP-0399856-B1 Pteridin-4 (3H)-ones, processes for their preparation and medicaments containing them LIPHA (FR) 1995-08-09 EP claimed
EP-0399856-A1 Pteridin-4 (3H)-ones, processes for their preparation and medicaments containing them LIPHA, LYONNAISE INDUSTRIELLE PHARMACEUTIQUE (FR) 1990-11-28 EP claimed
EP-4665868-A2 METHODS FOR MULTIPLEXED IMAGING AND DETECTION OF TARGETS President and Fellows of Harvard College (US) 2025-12-24 EP disclosed
WO-2025217257-A1 ENGINEERED CIRCULARIZED PEGRNAS AND USES THEREOF TRUSTEES OF BOSTON UNIVERSITY (US) 2025-10-16 WO disclosed
WO-2025021829-A1 MULTIVALENT CARGO-CARRYING COMPLEXES AND USES THEREOF ASTRAZENECA AB (SE) 2025-01-30 WO disclosed
WO-2025021831-A1 MULTIVALENT CARGO-CARRYING COMPLEXES AND USES THEREOF ASTRAZENECA AB (SE) 2025-01-30 WO disclosed
WO-2025021833-A1 MULTIVALENT CARGO-CARRYING COMPLEXES AND USES THEREOF ASTRAZENECA AB (SE) 2025-01-30 WO disclosed
EP-4490316-A1 MULTIPLEX FLUORESCENT CELLULAR AND TISSUE IMAGING WITH DNA ENCODED THERMAL CHANNELS AND USES THEREOF President And Fellows Of Harvard College (US) 2025-01-15 EP disclosed
WO-2025006923-A2 SINGLE-STRANDED NUCLEIC ACID ANALOGS FOR USE AS MUTATION RESISTANT ANTIBACTERIAL TREATMENT PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2025-01-02 WO disclosed
EP-4419536-A1 OLIGONUCLEOTIDES WITH 2'-DEOXY-2'-F-2'-C-METHYL NUCLEOTIDES Alnylam Pharmaceuticals, Inc. (US) 2024-08-28 EP disclosed
US-20020016309-A1 Imidazopyridine and imidazopyrimidine antiviral agents BRISTOL-MEYERS SQUIBB COMPANY 2002-02-07 US disclosed
WO-2001095910-A1 IMIDAZOPYRIDINE AND IMIDAZOPYRIMIDINE ANTIVIRAL AGENTS BRISTOL-MYERS SQUIBB COMPANY (US) 2001-12-20 WO disclosed
EP-1098644-A1 SUBSTITUTED BENZIMIDAZOLE ANTIVIRAL AGENTS Bristol-Myers Squibb Company (US) 2001-05-16 EP disclosed
WO-2000004900-A1 SUBSTITUTED BENZIMIDAZOLE ANTIVIRAL AGENTS BRISTOL-MYERS SQUIBB COMPANY (US) 2000-02-03 WO disclosed
EP-0399856-B1 Pteridin-4 (3H)-ones, processes for their preparation and medicaments containing them LIPHA (FR) 1995-08-09 EP disclosed
US-5270465-A 4(3H)-pteridinone compounds LIPHA, LYONNAISE INDUSTRILLE PHARMACEUTIQUE (FR) 1993-12-14 US disclosed
US-5167949-A Antiallergic LIPHA, LYONNAISE INDUSTRIELLE PHARMACEUTIQUE (FR) 1992-12-01 US disclosed
EP-0399856-A1 Pteridin-4 (3H)-ones, processes for their preparation and medicaments containing them LIPHA, LYONNAISE INDUSTRIELLE PHARMACEUTIQUE (FR) 1990-11-28 EP disclosed